Rekah Pharmaceutical Industry Ltd.

Tel Aviv Stock Exchange REKA.TA

Rekah Pharmaceutical Industry Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -2.14 M

Rekah Pharmaceutical Industry Ltd. Net Cash Used Provided By Financing Activities is USD -2.14 M for the year ending December 31, 2023, a 69.03% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Rekah Pharmaceutical Industry Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -6.92 M, a -674.45% change year over year.
Rekah Pharmaceutical Industry Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -893.69 K, a -115.06% change year over year.
Rekah Pharmaceutical Industry Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 5.94 M, a 251.45% change year over year.
Rekah Pharmaceutical Industry Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 1.69 M, a 77.19% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Tel Aviv Stock Exchange: REKA.TA

Rekah Pharmaceutical Industry Ltd.

CEO	Mr. Mordechai Elgrabli
IPO Date	Aug. 12, 2002
Location	Israel
Headquarters	30 Hamelach Street
Employees	427
Sector	Healthcare
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.

Key trends

Past 5 years